Vital Signs - Human Growth Hormone - A Multifaceted Paradigm for Specialty Pharma

Vital Signs - Human Growth Hormone - A Multifaceted Paradigm for Specialty Pharma

 

RELEASE DATE
01-Oct-2007
REGION
North America
Research Code: 9561-00-44-00-00
SKU: HC00500-NA-MR_03972
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC00500-NA-MR_03972
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on October 1, 2007, provides a strategic overview of issues and opportunities surrounding human growth hormone. Additionally, a company spotlight is provided for BioMS Medical, a biotechnology company with a core interest in the treatment of multiple sclerosis. Reimbursement and regulatory news from the FDA is also provided for the week of September 17 - September 21, 2007.

Table of Contents

This week's issue:

Related Research
This issue of Vital Signs, released on October 1, 2007, provides a strategic overview of issues and opportunities surrounding human growth hormone. Additionally, a company spotlight is provided for BioMS Medical, a biotechnology company with a core interest in the treatment of multiple sclerosis. Reimbursement and regulatory news from the FDA is also provided for the week of September 17 - September 21, 2007.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-44-00-00
Is Prebook No